Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution

BACKGROUND: Lung cancer is the deadliest and most diagnosed type of cancer worldwide. The 5-year survival rate of lung adenocarcinoma (LUAD) dropped significantly when tumor stages advanced. Patients who received surgically resecting at the pre-invasive stage had a 5-year survival rate of nearly 100...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jun, Ji, Yaxin, Weng, Xiaodan, Shao, Wei, Zhao, Jiaping, Chen, Hanlin, Shen, Lu, Wang, Fufeng, Meng, Qi, Wu, Xue, Wang, Xiaonan, Ou, Qiuxiang, Ke, Honggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328385/
https://www.ncbi.nlm.nih.gov/pubmed/37427097
http://dx.doi.org/10.3389/fonc.2023.1150098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328385/
https://www.ncbi.nlm.nih.gov/pubmed/37427097
http://dx.doi.org/10.3389/fonc.2023.1150098

Ejemplares similares